Pfizer Returns Bavencio Rights To Merck KGaA, Closing An IO Era

 
• By Jessica Merrill
  
door closing
Pfizer closed the door on its Bavencio collaboration • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business